The Palliative and Supportive Care in Oncology Symposium brings together health care professionals from all backgrounds to discuss models and integration of palliative and supportive care across various cancer care settings. This year’s Symposium addresses the latest research in advance care planning, guidelines and decision making, and managing immunotherapy side-effects.
Accreditation and Designation Statement
In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Society of Clinical Oncology designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Credit Designation Statement - Nurses
This CE activity is approved for 12.75 ANCC contact hours.
AAPA/NCCPA Credit Designation Statement – PAs
PAs may claim a maximum of 12.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
All non-physician attendees are welcome to submit a request for a Certificate of Participation, which may enable non-physicians to apply their meeting participation toward re-licensure. Please note, however, that all final decisions regarding certificate acceptance will be made by the licensing organization to which the certificate is submitted.
This symposium is designed for all members of the oncology team that are interested in the supportive and palliative care of patients with cancer: medical, radiation and surgical oncologists, nurses, physician assistants, residents and oncology fellows.
Educational Needs Statement
During the course of treatment for cancer, patients face a variety of unmet needs associated both with the effects of therapy and of the disease itself. These challenges include access to palliative care, challenging symptoms and side effects, communication barriers with the healthcare team, and difficulty coping with the cost of care among others.
The introduction and rapid expansion of novel therapies has uncovered new and unpredictable sets of toxicities, which must be prevented, identified, monitored, and managed in new ways. Patients continue to face challenges from traditional therapies, as well, such as those from traditional chemotherapeutic and hormonal therapeutic approaches; however, new therapies may offer novel approaches for persistent treatment and disease symptoms and side effects. Communication barriers between patients and clinicians exacerbate many of the challenges faced by patients, particularly in the palliative setting. Poor communication regarding a terminal prognosis and at end-of-life can pose particular hurdles to delivery of quality palliative and end-of-life care.
The 2018 Palliative and Supportive Care in Oncology Symposium seeks to promote the integration of palliative and supportive care practices, from diagnosis throughout the continuum of care in order to better address the needs of patients and their families, by providing a forum for presentation and discussion of current research and best practices in the field using a multi- and interdisciplinary approach.
Upon participation in this activity, attendees will be better able to
- Discuss the challenges of prognosis and palliative care management of patients with metastatic disease given the recent advances in cancer therapies and the ever-increasing immuno-oncology treatments;
- Identify new opportunities supporting the integration of palliative care in the assessment and treatment of disease and treatment related symptoms, including issues of opioid use management;
- Effectively manage the potential toxicities from cancer treatment; along with complexities from the use of combination treatment options between immunotherapy, chemotherapy and radiotherapy;
- Identify barriers to implementing technological innovations to provide better patient support in the outpatient palliative care oncology setting;
- Incorporate effective models of palliative care delivery for patients and their families in various clinical settings; and
- Recognize opportunities by the oncology team to improve outcomes for older patients who are a vulnerable population in need of special considerations during the care trajectory.
Disclaimer and Unlabeled Usage Statement
The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of ASCO, the Symposium Cosponsors, and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.